Sponsor:
Northwell Health
Code:
NCT06379425
Conditions
Pain, Postoperative
Postoperative Pain, Acute
Eligibility Criteria
Sex: Female
Age: 0+
Healthy Volunteers: Accepted
Interventions
Acetaminophen
Celecoxib
Gabapentin
Brief summary:
Conditions
Pain, Postoperative
Postoperative Pain, Acute
Study ID
NCT06379425
Start date
Mar 1, 2024
Status verified date
Oct, 2026
Completion date
Mar 1, 2027
Anticipated
Primary completion date
Jan 1, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 0+
Healthy Volunteers: Accepted
Enrollment
70 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Prevention
Arms
active comparator: Standard of Care (SOC) (acetaminophen)
experimental: Standard of Care (SOC) (acetaminophen) and investigational product (celecoxib + gabapentin)
Interventions
Acetaminophen
Celecoxib
Gabapentin
Primary outcome measure
Locations
Northwell Health South Shore Surgery Center
Recruiting
Bay Shore, New York, United States, 11706
Contacts
Principal Investigator:
Nirmala Pillalamarri, MD
Sponsor
Northwell Health
Last update posted
Oct 5, 2026
Last verified
Oct, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-25. This information was provided to ClinicalTrials.gov by Northwell Health on 2026-10-05. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.